Menon D K, Sargentoni J, Taylor-Robinson S D, Bell J D, Cox I J, Bryant D J, Coutts G A, Rolles K, Burroughs A K, Morgan M Y
Robert Steiner NMR Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
Hepatology. 1995 Feb;21(2):417-27.
Hepatic phosphorus-31 magnetic resonance spectroscopy (31P MRS) was undertaken in 85 patients with histologically proven cirrhosis of varying etiologies and functional severity. Reference data were acquired from 16 healthy volunteers who had no history or evidence of liver disease or alcohol abuse. In vivo hepatic 31P MR spectra were acquired with pulse angle 45 degrees and repetition times (TR) of 5 and 0.5 seconds. Peak area ratios of phosphomonoesters (PME), inorganic phosphate (Pi), and phosphodiesters (PDE) relative to beta ATP, and of PME relative to PDE were calculated from spectra acquired at TR 5 seconds. Estimates of saturation effects for individual resonances were obtained by dividing the peak height at TR 5 seconds by that at TR 0.5 seconds to yield a T1-related signal height ratio (SHR). When compared with reference values, the patients with liver disease showed a significantly higher PME/ATP (P < .0001), PME/PDE (P < .0001), PME SHR (P < .001), and Pi SHR (P < .02), and a lower PDE/ATP (P < .001) and PDE SHR (P < .001). The magnitude of these changes increased significantly and progressively with increasing functional impairment. In patients with compensated cirrhosis spectral appearances varied with etiology; thus, patients with postviral cirrhosis showed a significantly higher Pi/ATP; those with alcoholic cirrhosis, a significantly lower PDE/ATP; and those with cirrhosis secondary to primary sclerosing cholangitis, a significantly lower Pi/ATP than the healthy volunteers or other etiological groups. However, spectral appearances did not vary with etiology in patients with decompensated disease. In vitro 31P MRS of perchloric extracts of samples of liver tissue obtained from 10 patients with cirrhosis at transplant hepatectomy showed increases in levels of the soluble PME metabolites, phosphorylcholine and phosphorylethanolamine, and reductions in the levels of the soluble PDE metabolites, glycerophosphorylcholine and glycerophosphorylethanolamine. These changes suggest regenerative activity in cirrhotic livers. The increases in soluble phosphomonoesters in the aqueous extracts accounted for the increased PME/ATP ratio seen in the in vivo spectra, and might account for the increase in PME SHR. The reduction in soluble phosphodiesters in the aqueous extracts did not entirely account for the reduction PDE/ATP ratio seen in vivo.(ABSTRACT TRUNCATED AT 400 WORDS)
对85例经组织学证实病因和功能严重程度各异的肝硬化患者进行了肝脏磷-31磁共振波谱分析(31P MRS)。从16名无肝脏疾病或酒精滥用病史及证据的健康志愿者获取参考数据。采用45度脉冲角和5秒及0.5秒的重复时间(TR)采集体内肝脏31P MR波谱。根据在TR为5秒时采集的波谱计算磷酸单酯(PME)、无机磷酸(Pi)和磷酸二酯(PDE)相对于β-ATP的峰面积比,以及PME相对于PDE的峰面积比。通过将TR为5秒时的峰高除以TR为0.5秒时的峰高来获得各个共振的饱和效应估计值,以得出与T1相关的信号高度比(SHR)。与参考值相比,肝病患者的PME/ATP(P <.0001)、PME/PDE(P <.0001)、PME SHR(P <.001)和Pi SHR(P <.02)显著更高,而PDE/ATP(P <.001)和PDE SHR(P <.001)更低。这些变化的幅度随着功能损害的加重而显著且逐渐增加。在代偿期肝硬化患者中,波谱表现因病因而异;因此,病毒后肝硬化患者的Pi/ATP显著更高;酒精性肝硬化患者的PDE/ATP显著更低;原发性硬化性胆管炎继发肝硬化患者的Pi/ATP比健康志愿者或其他病因组显著更低。然而,失代偿期疾病患者的波谱表现不因病因而异。对10例肝硬化患者在移植肝切除术中获取的肝组织样本的高氯酸提取物进行体外31P MRS分析,结果显示可溶性PME代谢产物磷酸胆碱和磷酸乙醇胺水平升高,而可溶性PDE代谢产物甘油磷酸胆碱和甘油磷酸乙醇胺水平降低。这些变化提示肝硬化肝脏具有再生活性。水提取物中可溶性磷酸单酯的增加解释了体内波谱中PME/ATP比值的升高,也可能解释了PME SHR的增加。水提取物中可溶性磷酸二酯的降低并不能完全解释体内观察到的PDE/ATP比值的降低。(摘要截选至400字)